Agios

A big year for sickle cell
EP Vantage
Tue, 03/1/22 - 10:12 am
sickle cell disease
Agios
mitapivat
CRISPR Therapeutics
CTX001
clinical trials
Agios wins FDA approval for drug to treat rare form of anemia
Stat
Thu, 02/17/22 - 11:16 pm
Agios
mitapivat
pyruvate kinase deficiency
anemia
FDA
Servier gets a win for cancer drug Tibsovo, bought in $1.8bn Agios deal
Pharmaforum
Mon, 08/2/21 - 09:39 pm
Servier
Agios
M&A
Tibsovo
AML
ASH 2020 – Forma gets an early edge over Agios in sickle cell disease
EP Vantage
Tue, 12/8/20 - 10:30 am
ASH2020
Forma Therapeutics
Agios
sickle cell disease
FT-4202
Forma takes aim at Agios with new AML complete remission data
Endpoints
Mon, 10/26/20 - 11:01 am
Forma Therapeutics
sickle cell disease
clinical trials
Agios
AML
Cancer drugmaker Agios offers promising data from two studies testing blood disorder drug
Endpoints
Fri, 06/12/20 - 10:58 am
EHA
Agios
mitapivat
thalassemia
ESMO: Agios celebrates milestone win for ivosidenib in tough-to-treat bile duct cancer
Fierce Pharma
Mon, 09/30/19 - 10:41 am
Agios
bile duct cancer
Tibsovo
ESMO
Why Amgen, Lilly, J&J Are Interested In These Small Biotechs
Investors Business Daily
Sat, 09/16/17 - 12:11 pm
Amgen
Eli Lilly
JNJ
Exelixis
biotech
Theravance
Bavarian Nordic
Agios
Biohaven Pharmaceuticals
Progenics
Celgene embraces MTAP cancer deal with fast-moving collaborator Agios
Endpoints
Mon, 03/13/17 - 10:16 am
Celgene
MTAP
Agios
immuno-oncology
Celgene, Agios beat a short path to an FDA decision on AML drug
Endpoints
Wed, 03/1/17 - 08:53 pm
Celgene
Agios
FDA
AML
enasidenib
acute myeloid leukemia
The Most Important Keys To Celgene's Pipeline
Seeking Alpha
Sat, 01/21/17 - 11:32 am
Celgene
Revlimid
Acceleron
Juno Therapeutics
Agios
Agios Blood Cancer Drug Heading to Early FDA Filing by Partner Celgene
TheStreet.com
Wed, 09/7/16 - 08:16 pm
Agios
FDA
Celgene
acute myeloid leukemia
AG-221
Agios drug boosts hemoglobin in anemia patients in mid-stage trial
Bizjournals.com
Sun, 06/12/16 - 12:26 pm
Agios
anemia
clinical trials
AG-519
PK disorder
Agios slips on mixed solid tumor data for its Celgene-partnered cancer drug
Fierce Biotech
Tue, 11/10/15 - 09:37 am
Agios
solid tumors
Celgene
AG-120
Celgene and Agios Deliver Some Great "Bad" News
Investopedia
Thu, 06/18/15 - 09:15 am
Celgene
Agios
AG-348
AG-120
AG-221
blood cancer
The Best-Performing Biotechnology Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:32 pm
biotech
Avanir
OvaScience
Agios
Bluebird Bio
Receptos
Prosensa
Pernix
Achillion
Amicus Therapeutics
CytoSorbents
PTC Therapeutics
Framing Up Capital Efficiency In Early Stage Biotech
Forbes
Thu, 07/17/14 - 09:18 am
biotech
capital efficiency
Zafgen
IPOs
Agios
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
Thu, 06/12/14 - 09:33 am
M&A
Merck
Idenix
Achillion
Agios
Alkermes
Celldex Therapeutics
Vertex
Seattle Genetics
Epizyme
Bluebird, Agios: Preview of Next Week's Important Pipeline Updates
TheStreet.com
Fri, 06/6/14 - 09:34 am
Bluebird Bio
Agios
AG-221
Celgene
LentiGlobin
Agios' Experimental Leukemia Drug Makes Cancer Undetectable In Three Patients
Forbes
Mon, 04/7/14 - 08:34 am
Agios
AG-221
acute myeloid leukemia

Pages